Brief: Amicus Therapeutics Enters Into License Agreement With Trustees Of University Of Pennsylvania

Amicus Therapeutics

28/12/2022 22:12

Dec 28 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS INC - ON DEC 22, 2022, CO ENTERED INTO
A
LICENSE AGREEMENT WITH THE TRUSTEES OF THE UNIVERSITY OF
PENNSYLVANIA
    * AMICUS- CO ELIGIBLE FOR LOW DOUBLE-DIGIT PERCENT SHARE OF
REVENUE PENN GETS FROM THIRD-PARTY LICENSEES OF SOME PATENT
RIGHTS FROM DISCOVERY RESEARCH PROGRAM
    * AMICUS-CO,PENN TERMINATED COLLABORATION
AGREEMENT,PROCESS,DEVELOPMENT AGREEMENT, DATED MARCH 26, 2020
    * AMICUS THERAPEUTICS INC-AMICUS PAID TO PENN AN UNPAID
PORTION OF
SUCH DISCOVERY SUPPORT PAYMENTS AMOUNTING TO $20 MILLION

Source: (https://bit.ly/3PWJXSi)
Further company coverage:  FOLD.O 
 ((Reuters.Briefs@thomsonreuters.com;))